Re-Imagining Contraception Costs in Canada

Re-Imagining Contraception Costs in Canada

🎙 Women's Health Research Institute 👥 251 📅 November 26, 2025 ⏱ 59 min 👁 27 📄 expert opinion 🧭 2026-08-16
Available in: English (current) Français

Keywords

contraceptioncostyouthaccessCanada

Summary

This presentation by Dr. Sarah Munro and Dr. Madeleine Ennis from the Reproductive Choices Lab at UBC focuses on the Ask Us project, a youth co-led qualitative study examining contraception access in Canada. The speakers discuss the multiple dimensions of ‘cost’ beyond financial, including approachability, geographical accessibility, and appropriateness of care. They highlight system-level barriers and facilitators youth face, and specifically analyze the impacts of free prescription contraception and pharmacist prescribing policies in British Columbia. Key findings include low awareness of the policies among youth, positive attitudes towards free contraception, and concerns about privacy and confidentiality in pharmacies. The presentation emphasizes the importance of youth involvement in research and knowledge translation, and discusses implications for implementing free pharmacare across Canada. The study used participatory methods, including youth-led interviews and analysis, and partnered with over 190 community organizations. The speakers also reflect on the need for decision support for youth and the role of reproductive justice in their work.

158 words

Critical Evaluation

Value of the Information & Strength of the Argument

The value of the information is high, as it provides original qualitative data on youth perspectives on contraception costs and policy impacts in Canada. The argumentation is solid, grounded in a rigorous participatory research design with a large sample of youth and providers. The speakers effectively argue that cost is a multifaceted barrier, and their findings support the need for policy changes beyond just removing financial costs. However, the presentation is primarily descriptive and does not include quantitative analysis or comparative data, which limits the strength of some claims.

Scientific Rigor, Source Quality, Title Accuracy

The scientific rigor is strong, with the study protocol published in BMJ Open and funding from CIHR and Health Canada. The sources cited are credible, including peer-reviewed publications and policy documents. The title accurately reflects the content, which re-imagines contraception costs in a Canadian context. The presentation does not include a formal literature review, but it builds on existing evidence and guidelines, such as the Canadian Pediatric Society position statement. The adéquation between title and content is good, as the presentation indeed re-imagines costs beyond financial aspects.

191 words

Title / Content Match

The title accurately reflects the content, which re-imagines contraception costs beyond financial aspects to include access barriers and policy impacts.

Quality & Reliability

8/10

Presentation by established researchers with peer-reviewed funding and publications, but based on qualitative interviews and expert interpretation, not a systematic review or meta-analysis.

Key Moments

Cited Sources

Concurring Sources

  • Canadian Contraception Access Study — Related research on contraception access in Canada

Contribution & Novelties

This presentation provides novel insights into the multifaceted nature of contraception costs for youth in Canada, particularly highlighting the non-financial barriers that persist even when costs are covered. The youth co-led methodology is an innovative approach that ensures the research is relevant and accessible. The findings on the impacts of free contraception and pharmacist prescribing policies offer timely evidence for policy makers.

Pour aller plus loin :

102 words

Radar Profile

The radar profile shows high scores in quantity and quality of information, with moderate technical level and high reliability. This indicates a well-rounded, credible presentation suitable for a professional audience.

Reliability 8/10

💬 No comments were provided for analysis.